Wall Street analysts forecast that Biogen Inc. (BIIB) will report quarterly earnings of $4 per share in its upcoming release, pointing to a year-over-year decline of 0.5$2.38 billion, exhibiting a decline of 3.1% compared to the year-ago quarter.The consensus EPS estimate for the quarter has been revised 0.3% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimat ...